期刊文献+

天津地区IL-1Ra基因内含子2可变串联重复序列与脓毒症的相关性研究 被引量:1

Association of sepsis and the variable number of tandem repeat polymorphism in intron two of interleukin-1 receptor antagonist gene in Tianjin population
下载PDF
导出
摘要 目的:探讨白细胞介素-1受体拮抗剂(IL-1 Ra)基因第2内含子中可变串联重复序列(VNTR)多态性与脓毒症的相关关系。方法:应用PCR法,观察90例脓毒症患者、120例健康对照者的IL-1Ra基因VNTR多态性的分布。结果:两组人群中共发现了IL-1RNⅠ/ⅠI、L-1RNⅠ/ⅡI、L-1RNⅠ/Ⅳ3种基因型,以Ⅰ型等位基因为主,未发现III型和Ⅴ型。正常对照组中Ⅱ型等位基因和Ⅰ/Ⅱ基因型的分布频率与脓毒症组相比明显增加(8%vs2%,P<0.05;17%vs4%,P<0.05)。另外,不携带Ⅱ型等位基因的基因型(Ⅰ/Ⅰ和Ⅰ/Ⅳ)和非Ⅱ型等位基因携带者(Ⅰ,Ⅳ)与携带Ⅱ型等位基因的基因型(Ⅰ/Ⅱ)和Ⅱ型等位基因携带者相比发生脓毒症的相对危险度分别为4.3和4.0。结论I:L-1RNⅡ型等位基因可能在脓毒症的发生发展过程中具有潜在的保护作用。 Objective: To investigate the association of sepsis and variable number of tandem repeats (VNTR) polymorphism in the second intron of IL-1Ra gene. Methods: The distribution of VNTR polymorphism in IL-1Ra gene was observed by the method of PCR in 90 patients of sepsis and 120 healthy controls. Results: Three kinds genotypes, IL-1RN I / I ,IL-1RN I/II and IL-1RN I /IV were found in case group and healthy control group, and type- I allele were the mainly.The frequency of the type H alleles and the I / II genoty- pe in the normal control group was significantly increased compared with that in the sepsis group (0.08vs0.02, P〈0.05; 0.17 vs 0.04, P〈0.05), also, the relative risk of occurring sepsis between genotype ( I / I, I/IV) and ( I/II ) was 4.3 and the relative risk of acurring sepsis between ( I / IV) and ( II ) was 4.0. Conclusion: IL-1RN II alleles may have the potentially protective effect in the development of sepsis.
出处 《天津医科大学学报》 2010年第3期399-401,共3页 Journal of Tianjin Medical University
基金 天津市卫生局科技发展基金计划项目(05KYZ58)
关键词 白细胞介素1受体拮抗剂 基因多态性 脓毒症 Interleukin-1 receptor antagonist Gene polymorphism Sepsis
  • 相关文献

参考文献10

二级参考文献39

  • 1连丽娟.林巧稚妇科肿瘤学(第2版)[M].北京:人民卫生出版社,1994.533-544. 被引量:8
  • 2Dinarello CA. Biologic basis for interleukin-1 in disease. Blood, 1996, 87:2 095-147. 被引量:1
  • 3Hurme M,Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are coordinately regulated by both IL-IRa and IL-1beta genes. Eur J Immunol, 1996,28:2 598-602. 被引量:1
  • 4Witkin SS,Gerber S, Ledger W. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis, 2002, 34:204-209. 被引量:1
  • 5Libby P, Warner SJ, Friedman GB. Interleukin-1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest, 1998, 81:487-498. 被引量:1
  • 6Kastrati A, Koch W, Berger PB, Mehilli J, Stphenson K,Neurmann FJ. Protective role against restenosis from an interleukin-1 receptor antagoniat gone polymorphism in patients treatment with coronary stenting. JACC, 20110, 36:2 168-173. 被引量:1
  • 7Dewberry R, Holden H, Caussman D, Francis S. Interleukin-1 receptor antagonist expression in human endothelial cell and atherosclerosis. Arteriosler Thromb Vasc Biol, 2000, 20:2 394-400. 被引量:1
  • 8Francis SE, Cramp NJ, Burton AJ, Dewberry RM, Gunn J, Stephens-Lloyd A.Interleukin-1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty. Heart, 2001,86: 336-340. 被引量:1
  • 9Francis SE, Camp NJ,Dewberry RM, Gunn J, Syrris P, Carter ND. Interleukin- 1 receptor antagonist gene polymorphism and coronary artery disease. Circulation, 1999, 99:861-866. 被引量:1
  • 10Bioque G, Crusius J B A, Koutroubakis I, et al. Allelic polymorphism in IL-1β and IL-1 receptor antagonist(IL-1Ra) genes in inflammatory bowel disease[J]. Clin Exp Immunol,1995,102(2):379-383. 被引量:1

共引文献13

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部